Items Tagged ‘Triple Negative Breast Cancer’

February 21, 2018

Liquid Biopsy Can Help Predict Outcomes in Metastatic Triple-Negative Breast Cancer

By

A clinically relevant “liquid biopsy” test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer (TNBC), according to new research published by a multi-institutional team of researchers.1,2 Although TNBC represents just 10-15 percent of all breast diagnoses, the disease is responsible for 35 […]

View full entry

Tags: Breast Cancer, Liquid Biopsy, News, Triple Negative Breast Cancer


October 12, 2017

Immunotherapy Active Against Triple-Negative Breast Cancer

By

October is breast cancer awareness month and patients with triple-negative breast cancer (TNBC) should be aware that data from two clinical trials provide additional evidence that they may derive benefit from checkpoint inhibitor therapy.1-4 About Triple Negative Breast Cancer Approximately 12% of breast cancers are triple-negative breast cancers, meaning that they are estrogen-receptor negative (ER-), […]

View full entry

Tags: atezolizumab, Breast Cancer, checkpoint inhibitor, immunotherapy, keytruda, News, PD-1, pembrolizumab, Precision Cancer Medicine, Tecentriq, Triple Negative Breast Cancer